Evidence map›Paper›PMID 40141140›Full record

ArticleInternational journal of molecular sciences2025

A Comparative Study of Melittins from

Pachara Sattayawat, Thida Kaewkod, Saruda Thongyim, Chutipa Chiawpanit, Yupanun Wutti-In, Chutamas Thepmalee, Yingmanee Tragoolpua, Terd Disayathanoowat, Aussara Panya

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Combination of Melittin andInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pachara SattayawatDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-1272-544X
Thida KaewkodDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-1779-7629
Saruda ThongyimDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Chutipa ChiawpanitDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Yupanun Wutti-InCell Engineering for Cancer Therapy Research Group, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-6402-7195
Chutamas ThepmaleeDivision of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Yingmanee TragoolpuaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0754-0638
Terd DisayathanoowatDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-6416-2266
Aussara PanyaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.

Funding

Chiang Mai University
6 · The paper itself

Abstract

Lung cancer remains one of the most lethal malignancies, often diagnosed at advanced stages, leading to limited treatment options. Thus, identifying natural products with potent anti-cancer activity is crucial for improving treatment outcomes. While the melittin from

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungGefitinibLung NeoplasmsMelittenA549 CellsAnimalsApoptosisBeesCell Line, TumorCell MovementCell ProliferationCell SurvivalHumansAntineoplastic AgentsGefitinibMelittenanti-cancer peptidesbee venomEGFRmelittinNSCLC

Identifiers

PMID40141140
PMCPMC11941996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.